ARROWHEAD PHARMACEUTICALS, INC. (ARWR) /
The profitability of ARROWHEAD PHARMACEUTICALS, INC. over the past 10 years
Chart ARROWHEAD PHARMACEUTICALS, INC.: operating income, net income, fiscal 2016–2025 Open the chart →ARROWHEAD PHARMACEUTICALS, INC. reported a net loss of $1.63M in fiscal 2025, the latest fiscal year on file. That year it had operating income of $98.35M. It reported a profit in 1 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2020, 2021, 2022, 2023, 2024 and 2025. Its highest net income in these years was $67.97M, in fiscal 2019.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Sep 30, 2025 | $98.35M | -$1.63M |
| 2024ended Sep 30, 2024 | -$601.08M | -$599.49M |
| 2023ended Sep 30, 2023 | -$205M | -$205.28M |
| 2022ended Sep 30, 2022 | -$178.51M | -$176.06M |
| 2021ended Sep 30, 2021 | -$149.04M | -$140.85M |
| 2020ended Sep 30, 2020 | -$93.16M | -$84.55M |
| 2019ended Sep 30, 2019 | $61.19M | $67.97M |
| 2018ended Sep 30, 2018 | -$55.94M | -$54.45M |
| 2017ended Sep 30, 2017 | -$37M | -$34.38M |
| 2016ended Sep 30, 2016 | -$81.74M | -$81.72M |
Fiscal years as ARROWHEAD PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ARROWHEAD PHARMACEUTICALS, INC.
- The revenue of ARROWHEAD PHARMACEUTICALS, INC.
- The cash flow of ARROWHEAD PHARMACEUTICALS, INC.
- The debt of ARROWHEAD PHARMACEUTICALS, INC.
- All of ARROWHEAD PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- VICRVICOR CORPORATION
- ADCAGREE REALTY CORPORATION
- OSKOshkosh Corporation
- WLKWestlake Corporation
- CTVACorteva, Inc.
Not investment advice. This page shows what ARROWHEAD PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.